Generated by GPT-5-mini| Fiona Godlee | |
|---|---|
| Name | Fiona Godlee |
| Birth date | 1961 |
| Occupation | Physician, Editor, Journalist |
| Known for | Editor-in-Chief of The BMJ |
| Alma mater | University of Cambridge, St Mary's Hospital Medical School |
Fiona Godlee is a British physician, medical editor and advocate for research integrity who served as Editor-in-Chief of The BMJ. She has been prominent in debates involving medical publishing, evidence-based medicine, open access, conflict of interest transparency and public health policy. Her career spans clinical practice, academic publishing, and leadership within professional organisations.
Godlee was born in 1961 and is the daughter of noted paediatrician Richard Godlee and granddaughter of surgeon Sir Rickman Godlee. She read medicine at the University of Cambridge and trained clinically at St Mary's Hospital Medical School, which later became part of Imperial College School of Medicine. During her formative years she was influenced by mentors connected with Royal College of Physicians, Royal College of Surgeons and figures active in the history of NHS reform. Her early education intersected with institutions such as Addenbrooke's Hospital, Great Ormond Street Hospital, Guy's Hospital and academic centres linked to Medical Research Council fellowship schemes.
After qualifying as a physician she worked in clinical posts at hospitals including Royal Free Hospital and undertook research linked to Wellcome Trust-funded projects. Transitioning to medical journalism, she contributed to publications such as The BMJ and engaged with editorial bodies including the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors. She held editorial roles at organisations like BMJ Group and collaborated with academic publishers including Elsevier, Wiley-Blackwell and Oxford University Press. Her professional network included leaders from Lancet editorial offices, representatives of the Association of Medical Editors and activists from Open Access Scholarly Publishers Association. She has lectured at universities such as University College London, King's College London, University of Oxford and Harvard Medical School.
Appointed Editor-in-Chief in 2005, she led The BMJ through debates over peer review, research reproducibility and clinical trial transparency, interacting with regulatory bodies such as the Food and Drug Administration and the European Medicines Agency. Under her leadership The BMJ addressed issues raised by investigations into clinical trials funded by organisations like GlaxoSmithKline, Pfizer, Roche and AstraZeneca. She championed policies aligning with statements from the World Health Organization on trial registration and data sharing and worked with groups such as AllTrials and Transparency International on disclosure. Her tenure involved engagement with editorial peers at Nature, Science, The Lancet and specialty journals across platforms including PubMed Central, Scopus and Web of Science. She navigated controversies involving high-profile researchers affiliated with institutions such as University of Cambridge, Imperial College London, University College London and Stanford University.
Godlee has advocated for open access and stronger peer review standards, aligning with initiatives like the Budapest Open Access Initiative and the Berlin Declaration on Open Access to Knowledge in the Sciences and Humanities. She has spoken on conflicts of interest with reference to declarations promoted by the International Committee of Medical Journal Editors and transparency frameworks supported by the Coalition for Epidemic Preparedness Innovations and Wellcome Trust. Her public health commentary has engaged topics debated within forums of the Royal Society, British Medical Association, Academy of Medical Sciences and World Health Organization. She has supported research reproducibility efforts associated with the Reproducibility Project and methodological improvements discussed at meetings of the Cochrane Collaboration and the Institute of Medicine (US). Godlee has also written and debated policy with figures from Nuffield Trust, King's Fund, Health Foundation and contributed to discussions involving policymakers in the Department of Health and Social Care and members of Parliament.
Her work has been recognised by professional honours from bodies including the Royal Society of Medicine, Faculty of Public Health, Royal College of Physicians and awards associated with BMJ Publishing Group. She has been invited to keynote at conferences organised by World Congress on Public Health, European Public Health Association, International Congress on Peer Review and Biomedical Publication and received commendations from organisations such as Wellcome Trust and NHS Confederation. Academic institutions including University of Oxford, King's College London and University College London have acknowledged her contributions with invited fellowships and honorary positions.
Category:British physicians Category:Medical editors Category:Alumni of the University of Cambridge